LabCorp’s Acquisition of Chiltern Clears Antitrust Review Read more about LabCorp’s Acquisition of Chiltern Clears Antitrust Review
LabCorp Names Nationally Recognized Health-Policy Expert Dr. Brian Caveney As Enterprise-Wide Chief Medical Officer Read more about LabCorp Names Nationally Recognized Health-Policy Expert Dr. Brian Caveney As Enterprise-Wide Chief Medical Officer
LabCorp Prices $600,000,000 in 3.250% Senior Notes Due 2024 and $600,000,000 in 3.600% Senior Notes Due 2027 Read more about LabCorp Prices $600,000,000 in 3.250% Senior Notes Due 2024 and $600,000,000 in 3.600% Senior Notes Due 2027
LabCorp Announces Proposed Sale of Senior Notes Read more about LabCorp Announces Proposed Sale of Senior Notes
LabCorp to Acquire Chiltern for Approximately $1.2 Billion in Cash, Advancing Its Leadership in Drug Development Read more about LabCorp to Acquire Chiltern for Approximately $1.2 Billion in Cash, Advancing Its Leadership in Drug Development
LabCorp Announces Record Results in the Second Quarter of 2017 and Increases 2017 Guidance Read more about LabCorp Announces Record Results in the Second Quarter of 2017 and Increases 2017 Guidance
LabCorp Introduces New ADAMTS13 Test for Rare Life-Threatening Blood Clot Disorder Read more about LabCorp Introduces New ADAMTS13 Test for Rare Life-Threatening Blood Clot Disorder
LabCorp’s William Hanlon Appointed to Governing Committee of the National Evaluation System for health Technology Coordinating Center Read more about LabCorp’s William Hanlon Appointed to Governing Committee of the National Evaluation System for health Technology Coordinating Center
LabCorp and Novant Health Extend Laboratory Services Agreement Read more about LabCorp and Novant Health Extend Laboratory Services Agreement
